Patients who were strongly positive for anti-SAE1 autoantibodies and satisfied the IIM criteria may present with DM or CADM, with ILD potentially occurring either preceding or following IIM diagnoses. This evidence concerns the gene SAE1 and clinically amyopathic dermatomyositis.